Skip to main content

Table 1 Cytostatic compounds used in the breast cancer spheroid model

From: Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy – the SpheroNEO study

Name

PPC conzentration [μg/ml]

Literature source

Carboplatin

40.843

Go, Adjei, 1999 [53]

Cyclophosphamid

41.000

Egorin et al, 1989 [54]

Docetaxel

2.180

Baker et al, 2004 [55]; Bruno et al, 1998 [56]

Doxorubicin

1.640

Brana et al, 2014 [57]

Epirubicin

1.005

Reviewed in Fujimoto, 2007 [58]

Fluorouracil (5-FU)

100.000

Reviewed in Fujimoto, 2007 [58]

Paclitaxel

1.530

Gianni et al, 1995 [59]

Trastuzumab

88.000

Leyland-Jones, 2001 [60]

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us